Tesla, General Motors, Alibaba, and More: Why These Stocks Are in the Spotlight
The extended weekend is now over, and Wall Street is once again paying attention to the U.S. China trade war, the Indian stock market now that Modi has......(read more)
Posts Tagged ‘Astrazeneca Plc (AZN)’
Billionaire Ken Fisher is Bullish About These Dividend Stocks
Fisher Investments was founded in 1979 by billionaire Ken Fisher. The fee-only investment adviser managed more than $100 billion in assets as of July......(read more)
Hedge Fund and Insider Trading News: Daniel Loeb, Tom Steyer, Ray Dalio, AstraZeneca PLC (AZN), Alteryx Inc (AYX), and More
Dan Loeb’s Hedge Fund Trims Number of Nominees to Campbell Soup Board (CNBC) Daniel Loeb‘s hedge fund, Third Point, has trimmed the number......(read more)
Druckenmiller’s 4Q13 Portfolio Changes
Stan Druckenmiller is a billionaire, and was the long-time manager of Duquesne Capital. Now, he oversees a family office, but his investing strategy is......(read more)
Everything You Need to Know About the Upcoming Flu Season
To me, flu season is a lot like Christmas; there’s a defined time period when we expect it to occur, yet it seems to appear earlier and earlier......(read more)
An Excellent Investment in the Biotech Space?
According to the American Cancer Society, more than 60,000 new cases of thyroid cancer will be diagnosed in the U.S., and about 1,850 people are expected......(read more)
Johnson & Johnson (JNJ), AstraZeneca plc (ADR) (AZN), The Procter & Gamble Company (PG): The Priceless Health Business Every Investor Overlooks
Investors know Johnson & Johnson (NYSE:JNJ) for many things. It’s arguably health care’s biggest name. The company’s pharmaceutical......(read more)
AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?
The small patient pool for medullary thyroid cancer, or MTC, isn’t going to move the needle for a large pharmaceutical company. But Exelixis, Inc......(read more)
AstraZeneca plc (ADR) (AZN), Merck & Co., Inc. (MRK), Endocyte, Inc. (ECYT): Three Things You Need to Know About This Big Pharma Deal
Two big pharmaceutical players on opposite sides of the Atlantic have forged yet another bond. Through the years, London-based drugmaker AstraZeneca plc......(read more)
Omthera Pharmaceuticals Inc (OMTH), Elan Corporation, plc (ADR) (ELN), Onyx Pharmaceuticals, Inc. (ONXX): 3 Big Biotech Buyouts of 2013
The Chinese calendar says 2013 is the year of the snake, but the market says it’s the year of biotech. Major biotechnology ETFs and indices have......(read more)
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Could a Pair of Respiratory Disease Treatments Save This Big Pharma?
GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive......(read more)
Bristol Myers Squibb Co. (BMY), Merck & Co., Inc. (MRK): Is AstraZeneca plc (ADR) (AZN)’s Recent Acquisition Bigger Than Onyx?
AstraZeneca plc (ADR) (NYSE:AZN) may have missed out on acquiring the oncology platform of Onyx Pharmaceuticals, but it responded by pulling the trigger......(read more)
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Time to Bet on This Biotech Spinoff?
There hasn’t been a dull moment for investors of Theravance Inc (NASDAQ:THRX) since the company submitted an NDA for COPD/asthma drug BREO before......(read more)
AbbVie Inc (ABBV), AstraZeneca plc (ADR) (AZN): Neurocrine Biosciences, Inc. (NBIX) Nosedives on Mid-Stage Study Results
Investors hate to wake up and find that one of their stocks has opened nearly 30% lower than the prior day’s close. Unfortunately, that’s......(read more)
Dendreon Corporation (DNDN), ISIS Pharmaceuticals, Inc. (ISIS): Big Milestones Could Lead This Stock to Big Gains
I cannot emphasize enough how important having a deep and diverse pipeline, as well as numerous potential collaborative partners, can be in the biotechnology......(read more)
ISIS Pharmaceuticals, Inc. (ISIS) Scores Another Big Biotech Deal With Biogen Idec Inc. (BIIB)
Make that four collaborations between Biogen Idec Inc. (NASDAQ:BIIB) and ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) in the last two years. The pair announced......(read more)
AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY), GlaxoSmithKline plc (ADR) (GSK): Diabetes Drugmakers and Their “Definitely Maybe” Moment
Over the past decade, the Food and Drug Administration has taken multiple steps to improve the process by which drugs are developed and eventually brought......(read more)
AstraZeneca plc (ADR) (AZN), BlackBerry Ltd (BBRY): Tuesday’s Top Upgrades (and Downgrades)
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines......(read more)
AstraZeneca plc (ADR) (AZN), Bristol-Myers Squibb Co (BMY), BioMarin Pharmaceutical Inc. (BMRN): Three PDUFA Dates That Will Kick Off 2014
The phrase “PDUFA date” is thrown around frequently when discussing biotech and pharma companies. PDUFA stands for the Prescription Drug User......(read more)
Alkermes Plc (ALKS), Eli Lilly & Co. (LLY), AstraZeneca plc (ADR) (AZN): Tackling Pain and Addiction
Alkermes Plc (NASDAQ:ALKS) is primarily known for its schizophrenia and multiple sclerosis drug treatments. Schizophrenia treatments Risperdal Consta......(read more)
Amgen, Inc. (AMGN), AstraZeneca plc (ADR) (AZN): What’s the Big Deal About Onyx Pharmaceuticals, Inc. (ONXX) Anyway?
At the end of June, Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) announced that it had rejected an offer from Amgen, Inc. (NASDAQ:AMGN) that valued the......(read more)
AstraZeneca plc (ADR) (AZN), Eli Lilly & Co. (LLY), MannKind Corporation (MNKD): Three New Diabetes Drugs Possibly on the Way Soon
It’s no wonder that plenty of companies are developing diabetes drugs. There are more than 370 million people with diabetes worldwide. The global......(read more)
Osiris Therapeutics, Inc. (OSIR), Anacor Pharmaceuticals Inc (ANAC), Novavax, Inc. (NVAX): Three Humongous Health-Care Stocks This Week
A rising tide lifts all boats, but the opposite isn’t true in the stock market. The major indexes slipped this week, while a handful of health-care......(read more)
GlaxoSmithKline plc (ADR) (GSK), Novartis AG (ADR) (NVS): This Company’s Debt Might Be a Concern
GlaxoSmithKline plc (ADR) (NYSE:GSK) has been accused of making illegal payments to Chinese doctors and government officials by siphoning them through......(read more)
MannKind Corporation (MNKD), Novo Nordisk A/S (ADR) (NVO), Eli Lilly & Co. (LLY): A Good Drug That’s Too Risky to Buy
In a companion article a few days ago, I predicted that MannKind Corporation (NASDAQ:MNKD)‘s extended phase 3 program for its inhaled insulin,......(read more)
Medidata Solutions Inc (MDSO), salesforce.com, inc. (CRM): I’m Buying This High-Flying Stock Now
Every month, I select one or more stocks that I’ll be buying in real life for my Roth IRA. I’ve been doing this for over two years, and &#......(read more)
Questcor Pharmaceuticals Inc (QCOR), ISIS Pharmaceuticals, Inc. (ISIS): Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape
As human beings it can sometimes be difficult for us to see the good in a bad situation. In the biotech sector, where developing a drug can cost hundreds......(read more)
Teva Pharmaceutical Industries Ltd (ADR) (TEVA), AstraZeneca plc (ADR) (AZN): A Safe Investment With Growth Promise
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been stuck is share purgatory for a number of years. There have been no capital gains, and the......(read more)
3 Things You Need to Know From Astex Pharmaceuticals, Inc. (ASTX)’s Q2 Earnings
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) announced its second-quarter financial results on Thursday prior to the market open. The company reported a......(read more)
Three Things You Need to Know From Keryx Biopharmaceuticals (KERX)’s Q2 Earnings
Keryx Biopharmaceuticals (NASDAQ:KERX) announced its second-quarter results before the market opened on Thursday. Shares fell slightly as investors reacted......(read more)
Array Biopharma Inc (ARRY), AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): This Cancer Biotech Is Looking for Other Green Pastures
Array Biopharma Inc (NASDAQ:ARRY), a biotech company primarily focused on discovery of drugs for cancer treatment, is making forays into the asthma market......(read more)
China Petroleum & Chemical Corp (ADR) (SNP), AstraZeneca plc (ADR) (AZN): Three Companies With Dividend Yields You Don’t Want to Miss
Several companies are striving hard to manage their business and retain investors by providing an attractive dividend. These days, investors prefer a......(read more)
Three Things You Need to Know From Merck & Co., Inc. (MRK)’s Q2 Earnings
Merck & Co., Inc. (NYSE:MRK) announced its second quarter financial results prior to the market open on Tuesday. Here are the most important things......(read more)
AstraZeneca plc (ADR) (AZN) and Bristol Myers Squibb Co. (BMY): 2 Keys to Success for This Diabetes Drug’s Second Chance
If at first you don’t succeed, try, try again. We’ve heard that old saw many times, but it’s good advice. It’s also advice that......(read more)
Bristol Myers Squibb Co. (BMY), AstraZeneca plc (ADR) (AZN): Expanding P/E Saved This Pharma Investment
So much for Bristol Myers Squibb Co. (NYSE:BMY)‘s long-term post-Plavix guidance. Three years ago, the company told investors not to worry. It......(read more)
Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Will This Biotech Bidding War Lead You to Larger Gains?
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) added 3% to its one-month 60% gains on Monday because of continued speculation of a buyout. Reportedly, four......(read more)
Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Three Healthcare Stocks for Growth and Dividends
The healthcare sector has been one of the best sectors for dividend hunters — most of the companies operating in the sector generate massive cash......(read more)
AstraZeneca plc (ADR) (AZN), Eli Lilly & Co. (LLY): The Diabetes Pipeline With a Clog
Big pharma placed its bets on a new class of diabetes drugs called SGLT2. Last year, buzz surrounded late-stage projects from Johnson and Johnson (NYSE......(read more)
Four Potential Suitors for Onyx Pharmaceuticals, Inc. (ONXX)
The “people familiar with the matter” are out in full force spouting off about who’s bidding for Onyx Pharmaceuticals, Inc. (NASDAQ......(read more)
AstraZeneca plc (ADR) (AZN), Actavis Inc (ACT): Can Fish Oil Help This Drug Giant Regain its Mojo?
AstraZeneca plc (ADR) (NYSE:AZN)’s financial results have been on a downward spiral lately, as patent expirations have led to sharp declines in sales......(read more)
Amarin Corporation plc (ADR) (AMRN) Shares Sink on Secondary Offering
“More means less.” Amarin Corporation plc (ADR) (NASDAQ:AMRN) demonstrated this seemingly contradictory maxim today following its announcement......(read more)
The Medicines Company (MDCO), AstraZeneca plc (ADR) (AZN): A Small-Cap Pharmaceutical Company With 2014 in Its Sights
A few months back, Barron’s featured an intriguing pharmaceutical company that goes by the name The Medicines Company (NASDAQ:MDCO). This stock......(read more)
How Much Is Onyx Pharmaceuticals, Inc. (ONXX) Really Worth?
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is having a garage sale, but it doesn’t appear that Amgen, Inc. (NASDAQ:AMGN) has been invited. The promising......(read more)
TAL International Group, Inc. (TAL), Annaly Capital Management, Inc. (NLY) – High Yield: Stocks or Bonds?
A few weeks ago, CAPS player Valyooo started a lively debate with a blog entry asking for opinions on stocks vs. high-yield bonds. Since then, the Fed......(read more)
AstraZeneca plc (ADR) (AZN), PDL BioPharma Inc. (PDLI): Tempting Healthcare Dividend Stocks to Avoid
When screening for health-care dividend stocks, it’s tempting to look for the ones with the highest yield. On the surface, larger dividend payments......(read more)
ISIS Pharmaceuticals, Inc. (ISIS): This Anti-Sense Bet Makes Sense
In the last couple of years, the biotechnology industry has been on a roll. The large number of drug approvals and the dreaded patent cliff has positively......(read more)
Merck & Co., Inc. (MRK) Stock Depends on Januvia More Than Ever
Merck & Co., Inc. (NYSE:MRK) stock has become dependent on its diabetes drug Januvia over the past couple of years for revenue growth. The franchise......(read more)
AstraZeneca plc (ADR) (AZN), Sanofi SA (ADR) (SNY): Don’t Ignore These European Healthcare Stocks
Healthcare stocks have rallied over the past couple years, and for good reason. Not only is the global economy gaining traction, but the demographic trends......(read more)
Amarin Corporation plc (ADR) (AMRN), AstraZeneca plc (ADR) (AZN), Omthera Pharmaceuticals Inc (OMTH): Three Stocks Near 52-Week Lows Worth Buying
Just as we examine companies each week that may be rising past their fair value, we can also find companies potentially trading at bargain prices. While......(read more)
What These Ratios Tell Us About GlaxoSmithKline plc (ADR) (GSK)
LONDON — Before I decide whether to buy a company’s shares, I always like to look at two core financial ratios — return on equity ......(read more)
